治疗白内障的药理学策略:从分子向到临床翻译
Laura de Diego-García1, Raquel Rejas-González2, Ignacio Cereza Latre1
1Department of Biochemistry and Molecular Biology, Facultad de Óptica y Optometría, Universidad Complutense de Madrid, 28037 Madrid, Spain.
International journal of molecular sciences
|June 26, 2025
概括
药物治疗对延迟或逆转白内障,这是导致失明的主要原因,显示出希望. 研究重点是抗氧化剂和其他药物,以解决潜在的机制,如氧化应激和蛋白质聚合.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 生物化学 生物化学
背景情况:
- 白内障,或透镜变暗,是全球可逆失明的主要原因.
- 老龄化和糖尿病是主要的危险因素,增加了全球白内障负担.
- 目前的治疗主要是外科手术,这凸显了对非侵入性替代品的需求.
研究的目的:
- 审查目前对白内障药物治疗的进展.
- 探索针对白内障发生的分子机制的新型治疗方法.
- 概述这些治疗方法临床整合的挑战和未来前景.
主要方法:
- 审查最近关于白内障发生机制的研究.
- 分析新兴的药理学药剂及其点.
- 评估潜在的治疗策略,包括抗氧化剂,伴侣剂和酶抑制剂.
主要成果:
- 氧化应激,失调和高血糖引起的事件是白内障形成的关键.
- 抗氧化剂,小分子陪伴剂和阿尔多缩酶抑制剂等药理学剂显示出潜在的抗氧化作用.
- 这些药物旨在稳定或恢复透镜蛋白结构和透明度.
结论:
- 药理学策略为白内障手术提供了一个潜在的非侵入性替代方案.
- 进一步的研究对于优化药物输送,确保长期安全性和确认临床疗效至关重要.
- 开发有效的药理疗法可能会对与年龄有关的白内障和糖尿病白内障的管理产生重大影响.
相关概念视频
Targets for Drug Action: Overview
7.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.5K
Open Angle Glaucoma: Treatment
591
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
591
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Angle Closure Glaucoma: Treatment
708
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
708
Glaucoma: Overview
789
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
789
Atherosclerosis III: Management
42
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42


